The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(6-bromo-2-(4-methoxyphenyl)-2'-oxospiro[chromane-4,5'-oxazolidin]-3'-yl)acetic acid ID: ALA5289568
Max Phase: Preclinical
Molecular Formula: C20H18BrNO6
Molecular Weight: 448.27
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C2CC3(CN(CC(=O)O)C(=O)O3)c3cc(Br)ccc3O2)cc1
Standard InChI: InChI=1S/C20H18BrNO6/c1-26-14-5-2-12(3-6-14)17-9-20(11-22(10-18(23)24)19(25)28-20)15-8-13(21)4-7-16(15)27-17/h2-8,17H,9-11H2,1H3,(H,23,24)
Standard InChI Key: HQTKHUJWZXDFCW-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.4286 -0.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7141 0.0935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3816 0.5784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1266 1.3630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3017 1.3630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0467 0.5784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -0.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -1.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7141 -1.5563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4286 -1.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1431 -1.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8575 -1.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8575 -0.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1431 0.0935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5392 2.0777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1108 2.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9360 2.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3486 2.7924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3486 1.3630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5721 0.0937 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-0.7148 -1.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7150 -2.3817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4280 -2.7924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1428 -2.3796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1444 -1.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4326 -1.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8575 -2.7922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5721 -2.3796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
5 4 1 0
6 5 1 0
2 6 1 0
2 7 1 0
7 8 1 0
8 9 1 0
1 10 1 0
10 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
14 1 2 0
13 14 1 0
4 15 2 0
5 16 1 0
16 17 1 0
17 18 2 0
17 19 1 0
13 20 1 0
21 8 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
24 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 448.27Molecular Weight (Monoisotopic): 447.0317AlogP: 3.71#Rotatable Bonds: 4Polar Surface Area: 85.30Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.83CX Basic pKa: ┄CX LogP: 3.18CX LogD: -0.31Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.77Np Likeness Score: 0.31
References 1. Fernandes GFS, Scarim CB, Kim SH, Wu J, Castagnolo D.. (2023) Oxazolidinones as versatile scaffolds in medicinal chemistry., 14 (5): [PMID:37252095 ] [10.1039/d2md00415a ]